BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 6856998)

  • 1. Protection against Fasciola hepatica in rats with adult fluke antigen in Freund's adjuvant: influence of antigen batch, antigen dose and number of sensitising injections.
    Oldham G
    Res Vet Sci; 1983 Mar; 34(2):240-4. PubMed ID: 6856998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
    Sandeman RM; Howell MJ; Campbell NJ
    Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attempts to demonstrate a 'host antigen' effect by the experimental transfer of adult Fasciola hepatica into recipient animals immunised against the donor.
    Hughes DL; Harness E
    Res Vet Sci; 1973 Mar; 14(2):151-4. PubMed ID: 4805137
    [No Abstract]   [Full Text] [Related]  

  • 5. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different stages of Fasciola hepatica capable of inducing immunity and the susceptibility of various stages to immunological attack in the sensitised rat.
    Hughes DL; Harness E; Doy TG
    Res Vet Sci; 1981 Jan; 30(1):93-8. PubMed ID: 7244387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasciola hepatica: studies on vaccination of rats and mice with a surface antigen prepared from fluke homogenate by means of a monoclonal antibody.
    Hanna RE; Anderson A; Trudgett AG
    Res Vet Sci; 1988 Mar; 44(2):237-41. PubMed ID: 3291030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats.
    van Milligen FJ; Cornelissen JB; Bokhout BA
    Exp Parasitol; 2000 Mar; 94(3):163-71. PubMed ID: 10831381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in rats and cattle to primary infections with Fasciola hepatica.
    Oldham G
    Res Vet Sci; 1985 Nov; 39(3):357-63. PubMed ID: 4081342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: immunisation of rats by intraperitoneal injection of adult fluke antigen in Freund's adjuvant.
    Oldham G; Hughes DL
    Exp Parasitol; 1982 Aug; 54(1):7-11. PubMed ID: 6284547
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines.
    Mulcahy G; O'Connor F; Clery D; Hogan SF; Dowd AJ; Andrews SJ; Dalton JP
    Res Vet Sci; 1999 Aug; 67(1):27-33. PubMed ID: 10425237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of mice and sheep with Fh12 FABP from Fasciola hepatica using the new adjuvant/immunomodulator system ADAD.
    Martínez-Fernández AR; Nogal-Ruiz JJ; López-Abán J; Ramajo V; Oleaga A; Manga-González Y; Hillyer GV; Muro A
    Vet Parasitol; 2004 Dec; 126(3):287-98. PubMed ID: 15567592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica.
    Mulcahy G; O'Connor F; McGonigle S; Dowd A; Clery DG; Andrews SJ; Dalton JP
    Vaccine; 1998; 16(9-10):932-9. PubMed ID: 9682340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The experimental transfer of immature Fasciola hepatica from donor mice and hamsters to rats immunised against the donors.
    Hughes DL; Harness E
    Res Vet Sci; 1973 Mar; 14(2):220-2. PubMed ID: 4805143
    [No Abstract]   [Full Text] [Related]  

  • 17. Induced infectious bovine keratoconjunctivitis: vaccination with whole cell bacterins of Moraxella bovis mixed with Freund's incomplete adjuvant.
    Hughes DE; Pugh GW; Booth GD
    Am J Vet Res; 1977 Nov; 38(11):1905-7. PubMed ID: 931173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of rats against Fasciola hepatica using crude antigens conjugated with Freund's adjuvant or oligodeoxynucleotides.
    Cervi L; Borgonovo J; Egea M; Chiapello L; Masih D
    Vet Immunol Immunopathol; 2004 Jan; 97(1-2):97-104. PubMed ID: 14700541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hepatic changes and local and systemic immune responses in goats immunized with recombinant Peroxiredoxin (Prx) and challenged with Fasciola hepatica.
    Mendes RE; Pérez-Ecija RA; Zafra R; Buffoni L; Martínez-Moreno A; Dalton JP; Mulcahy G; Pérez J
    Vaccine; 2010 Apr; 28(16):2832-40. PubMed ID: 20153792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.